ART: Clinical Trials

1 trial for ART, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Active not recruiting 1

Follow ART: new trials by email Literature Review of ART trials Research Report on ART

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Accelerated ART Initiation for PWHIV Who Are Out of Care
The Accelerate model of care, bictegravir/emtricitabine/tenofovir alafenamide 50/200/25 mg - HIV Infections, ART
Phase 4Active not recruitingUniversity of Missouri-Columbia1202024-04-292026-08-05

Narrower conditions

HIV Infections (1)  ·  Patient Compliance (1)

Broader conditions

Behavior (1)  ·  Blood-Borne Infections (1)  ·  Communicable Diseases (1)  ·  Genital Diseases (1)  ·  Health Behavior (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Infections (1)  ·  Lentivirus Infections (1)  ·  Patient Acceptance of Health Care (1)  ·  RNA Virus Infections (1)  ·  Retroviridae Infections (1)  ·  Sexually Transmitted Diseases (1)  ·  Sexually Transmitted Diseases, Viral (1)  ·  Treatment Adherence and Compliance (1)

Interventions

Emtricitabine (1)  ·  bictegravir (1)  ·  tenofovir alafenamide (1)

Sponsors

University of Missouri-Columbia (1)

Countries

United States (1)

Top investigators

Dima Dandachi, MD, MPH (1)